<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(9)</volume><submitter>Mansur A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Primary lung signet-ring cell carcinoma (LSRCC) is a rare form of aggressive lung cancer whose clinical features remain inadequately discerned. The objective of this study was to evaluate the clinicopathological characteristics and independent prognostic factors of primary LSRCC.&lt;h4>Methods&lt;/h4>Overall survival (OS) of patients with LSRCC, lung adenocarcinoma (LAC), and lung mucinous adenocarcinoma (LMAC) in the National Cancer Database from 2004 to 2018 was evaluated using Kaplan-Meier and multivariable Cox proportional hazards modeling. Independent prognostic indicators for patients with LSRCC were determined using multivariable Cox proportional hazards analysis.&lt;h4>Results&lt;/h4>A total of 1,705 LSRCC, 504,006 LAC, and 15,883 LMAC patients were included in our analysis.</pubmed_abstract><journal>Journal of thoracic disease</journal><pagination>5899-5908</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11494572</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Primary lung signet-ring cell carcinoma: a national analysis.</pubmed_title><pmcid>PMC11494572</pmcid><pubmed_authors>Mansur A</pubmed_authors><pubmed_authors>Saleem Z</pubmed_authors><pubmed_authors>Potter AL</pubmed_authors><pubmed_authors>Senthil P</pubmed_authors><pubmed_authors>Yang CJ</pubmed_authors><pubmed_authors>Mathey-Andrews C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Primary lung signet-ring cell carcinoma: a national analysis.</name><description>&lt;h4>Background&lt;/h4>Primary lung signet-ring cell carcinoma (LSRCC) is a rare form of aggressive lung cancer whose clinical features remain inadequately discerned. The objective of this study was to evaluate the clinicopathological characteristics and independent prognostic factors of primary LSRCC.&lt;h4>Methods&lt;/h4>Overall survival (OS) of patients with LSRCC, lung adenocarcinoma (LAC), and lung mucinous adenocarcinoma (LMAC) in the National Cancer Database from 2004 to 2018 was evaluated using Kaplan-Meier and multivariable Cox proportional hazards modeling. Independent prognostic indicators for patients with LSRCC were determined using multivariable Cox proportional hazards analysis.&lt;h4>Results&lt;/h4>A total of 1,705 LSRCC, 504,006 LAC, and 15,883 LMAC patients were included in our analysis.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-03T23:51:53.506Z</modification><creation>2025-04-03T23:51:53.506Z</creation></dates><accession>S-EPMC11494572</accession><cross_references><pubmed>39444872</pubmed><doi>10.21037/jtd-24-102</doi></cross_references></HashMap>